tiprankstipranks
Trending News
More News >
Coherus Biosciences (CHRS)
NASDAQ:CHRS
US Market

Coherus Biosciences (CHRS) Balance Sheet

Compare
1,658 Followers

Coherus Biosciences Balance Sheet

Coherus Biosciences's total assets for Q4 2025 were $258.34M, a decrease of -49.98% from the previous quarter. CHRS total liabilities were $197.33M for the fiscal quarter, a -53.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 258.34M$ 448.53M$ 629.60M$ 480.85M$ 679.33M
Total Liabilities
$ 197.33M$ 580.52M$ 823.03M$ 618.26M$ 581.61M
Total Equity Gross Minority
$ 61.01M$ -131.99M$ -193.43M$ -137.42M$ 97.73M
Other Metrics
Currency in USD

Coherus Biosciences Debt to Assets